Monocarboxylate Transporter 8 Modulates the Viability and Invasive Capacity of Human Placental Cells and Fetoplacental Growth in Mice

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Vasilopoulou, Elisavet ^a   Loubière, Laurence S ^a   Heuer, Heike ^b   Trajkovic Arsic, Marija ^b   Darras, Veerle M ^c   Visser, Theo J ^d   Lash, Gendie E ^e   Whitley, Guy S ^f   McCabe, Christopher J ^a   Franklyn, Jayne A ^a   Kilby, Mark D ^a   Chan, Shiao Y ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS GROWTH; FETUS WEIGHT; HORMONE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MATING; MOUSE; NONHUMAN; PLACENTA DEVELOPMENT; PLACENTA WEIGHT; PROTEIN EXPRESSION; TROPHOBLAST; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENGLAND; FEMALE; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MONOCARBOXYLIC ACID TRANSPORTERS; ORGAN SIZE; PLACENTA; PREGNANCY; RNA, SMALL INTERFERING; THYROID HORMONES; TROPHOBLASTS;

MUS;

EID: 84878924571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065402     Document Type: Article

References (52)

1. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, et al. (2002) Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12: 63-68.
2. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, et al. (2005) Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105: 239-245.
3. LaFranchi SH, Haddow JE, Hollowell JG, (2005) Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid 15: 60-71.
4. Mestman JH, (2004) Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18: 267-288.
5. Kilby MD, Barber K, Hobbs E, Franklyn JA, (2005) Thyroid hormone action in the placenta. Placenta 26: 105-113.
6. Loubière LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, et al. (2010) Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 31: 295-304.
7. Loubiere LS, Vasilopoulou E, Glazier JD, Taylor PM, Franklyn JA, et al. (2012) Expression and function of thyroid hormone transporters in the microvillous plasma membrane of human term placental syncytiotrophoblast. Endocrinology 153: 6126-6135.
8. Barber KJ, Franklyn JA, McCabe CJ, Khanim FL, Bulmer JN, et al. (2005) The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab 90: 1655-1661.
9. Kilby MD, Verhaeg J, Gittoes N, Somerset DA, Clark PM, et al. (1998) Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J Clin Endocrinol Metab 83: 2964-2971.
10. Chan S, Kachilele S, Hobbs E, Bulmer JN, Boelaert K, et al. (2003) Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab 88: 4488-4495.
11. Mortimer RH, Galligan JP, Cannell GR, Addison RS, Roberts MS, (1996) Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. J Clin Endocrinol Metab 81: 2247-2249.
12. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, et al. (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278: 40128-40135.
13. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH, (2006) Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol 20: 2761-2772.
14. Lafreniere RG, Carrel L, Willard HF, (1994) A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Hum Mol Genet 3: 1133-1139.
15. Price NT, Jackson VN, Halestrap AP, (1998) Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem J 329 (Pt 2): 321-328.
16. Friesema EC, Visser WE, Visser TJ, (2010) Genetics and phenomics of thyroid hormone transport by MCT8. Mol Cell Endocrinol 322: 107-113.
17. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S, (2004) A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74: 168-175.
18. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, et al. (2004) Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364: 1435-1437.
19. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, et al. (2005) Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77: 41-53.
20. Heuer H, Visser TJ, (2009) Minireview: Pathophysiological importance of thyroid hormone transporters. Endocrinology 150: 1078-1083.
21. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S, (2006) Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147: 4036-4043.
22. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, et al. (2007) Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117: 627-635.
23. Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, et al. (2006) Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol 189: 465-471.
24. Vasilopoulou E, Loubiere LS, Martin-Santos A, McCabe CJ, Franklyn JA, et al. (2010) Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal and growth-restricted pregnancies. J Clin Endocrinol Metab 95: 4762-4770.
25. Oki N, Matsuo H, Nakago S, Murakoshi H, Laoag-Fernandez JB, et al. (2004) Effects of 3,5,3′-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab 89: 5213-5221.
26. Laoag-Fernandez JB, Matsuo H, Murakoshi H, Hamada AL, Tsang BK, et al. (2004) 3,5,3′-Triiodothyronine down-regulates Fas and Fas ligand expression and suppresses caspase-3 and poly (adenosine 5′-diphosphate-ribose) polymerase cleavage and apoptosis in early placental extravillous trophoblasts in vitro. J Clin Endocrinol Metab 89: 4069-4077.
27. Matsuo H, Maruo T, Murata K, Mochizuki M, (1993) Human early placental trophoblasts produce an epidermal growth factor-like substance in synergy with thyroid hormone. Acta Endocrinol (Copenh) 128: 225-229.
28. Lash GE, Naruse K, Innes BA, Robson SC, Searle RF, et al. (2010) Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trophoblast in early human pregnancy. Placenta 31: 545-548.
29. Cartwright JE, Holden DP, Whitley GS, (1999) Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide. Br J Pharmacol 128: 181-189.
30. Greenwood SL, Clarson LH, Sides MK, Sibley CP, (1996) Membrane potential difference and intracellular cation concentrations in human placental trophoblast cells in culture. J Physiol 492 (Pt 3): 629-640.
31. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118: 1567-1582.
32. James SR, Franklyn JA, Reaves BJ, Smith VE, Chan SY, et al. (2009) Monocarboxylate transporter 8 in neuronal cell growth. Endocrinology 150: 1961-1969.
33. Suzuki S, Mori J, Hashizume K, (2007) mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol. Trends Endocrinol Metab 18: 286-289.
34. Vie MP, Evrard C, Osty J, Breton-Gilet A, Blanchet P, et al. (1997) Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein. Mol Endocrinol 11: 1728-1736.
35. Dash PR, McCormick J, Thomson MJ, Johnstone AP, Cartwright JE, et al. (2007) Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of protein kinase Cepsilon. Exp Cell Res 313: 3421-3431.
36. Coan PM, Ferguson-Smith AC, Burton GJ, (2004) Developmental dynamics of the definitive mouse placenta assessed by stereology. Biol Reprod 70: 1806-1813.
37. Laga EM, Driscoll SG, Munro HN, (1973) Quantitative studies of human placenta. I. Morphometry. Biol Neonate 23: 231-259.
38. Reyns GE, Janssens KA, Buyse J, Kuhn ER, Darras VM, (2002) Changes in thyroid hormone levels in chicken liver during fasting and refeeding. Comp Biochem Physiol B Biochem Mol Biol 132: 239-245.
39. Koopdonk-Kool JM, de Vijlder JJ, Veenboer GJ, Ris-Stalpers C, Kok JH, et al. (1996) Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab 81: 2154-2158.
40. Kinne A, Roth S, Biebermann H, Kohrle J, Gruters A, et al. (2009) Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent. J Mol Endocrinol 43: 263-271.
41. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, et al. (2001) Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 142: 4339-4348.
42. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, et al. (2001) Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 142: 2005-2012.
43. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, et al. (2008) Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22: 1357-1369.
44. Trajkovic-Arsic M, Visser TJ, Darras VM, Friesema EC, Schlott B, et al. (2009) Consequences of Monocarboxylate Transporter 8 Deficiency for Renal Transport and Metabolism of Thyroid Hormones in Mice. Endocrinology 151: 802-809.
45. Emerson CH, Bambini G, Alex S, Castro MI, Roti E, et al. (1988) The effect of thyroid dysfunction and fasting on placenta inner ring deiodinase activity in the rat. Endocrinology 122: 809-816.
46. Hamilton GS, Lysiak JJ, Han VK, Lala PK, (1998) Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res 244: 147-156.
47. Visser WE, Friesema EC, Visser TJ, (2010) Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 25: 1-14.
48. Wirth EK, Sheu SY, Chiu-Ugalde J, Sapin R, Klein MO, et al. (2011) Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy. Eur J Endocrinol 165: 555-561.
49. Kinne A, Kleinau G, Hoefig CS, Gruters A, Kohrle J, et al. (2010) Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem 285: 28054-28063.
50. Coan PM, Angiolini E, Sandovici I, Burton GJ, Constancia M, et al. (2008) Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J Physiol 586: 4567-4576.
51. Angiolini E, Fowden A, Coan P, Sandovici I, Smith P, et al. (2006) Regulation of placental efficiency for nutrient transport by imprinted genes. Placenta 27 Suppl A: S98-102.
52. Fowden AL, Sferruzzi-Perri AN, Coan PM, Constancia M, Burton GJ, (2009) Placental efficiency and adaptation: endocrine regulation. J Physiol 587: 3459-3472.